There's a lot of buzz around mRNA #cancervaccines#, but how do they actually work? These vaccines help train your body’s immune system to recognize the unique genetic signature of cancer cells. Once activated, the immune system can: 🔹 Target and attack cancer cells while helping spare healthy cells 🔹 Work alongside other cancer treatments 🔹 Create a lasting immune response that may help prevent cancer from returning or spreading 📽️ Hear more from Dr. Vinod Balachandran (@TheVinodLab), Director of the Olayan Center for Cancer Vaccines at MSK, about what patients should know about experimental mRNA cancer vaccines.

Cancer vaccines were written off for decades. AI is the reason they suddenly work. @Ovid_ARK, PhD on the Moderna and Merck melanoma data and why renal, colorectal, and lung could be next.

With cancer vaccines now being discovered with AI ($MRNA), it seems that the US government might actually grow its way out of its budget deficit. It feels like we're in the early innings of the healthcare system becoming unburdened by many terminal illnesses.

AstraZeneca is considering developing cancer vaccines and jumping into one of the hottest areas of oncology research where questions still remain over how broadly the technology will work

🔊 A successful melanoma vaccine trial is raising hopes that personalized cancer vaccines could one day be used against lung, pancreatic, colon and other cancers. Hear more from @mygershberg on Reuters World News

Stripe's @RuxandraTeslo on why today's Moderna Phase 3 melanoma win probably won't hold in lung cancer or other solid tumors: "People are betting on Moderna's platform, so they expect these results won't just hold in skin cancer. They will also repeat themselves in other types of solid cancer, for example lung cancer. That might happen or it might not happen." "Skin cancer is the ideal cancer for cancer vaccines because it has this very high mutational burden, which allows the immune system to recognize the tumor very well. It's the cancer that responds so well to all immunotherapies." "Here we have seen the most bullish cancer, the best cancer for this type of vaccine. I'm excited about results in the future, but that is a big caveat, that we've seen the most favorable terrain in which these vaccines could be tested." @WorksInProgMag @stripe

What does AI research look like on one of the UK’s most powerful supercomputers?   Mohamed Awad visited Isambard-AI at @BristolUni (BriCS) to see how its computing power is helping researchers advance work - from personalized cancer vaccines to dementia diagnosis.   The future of UK research and discovery is being built on Arm.